Abstract
Background and Objectives: Acute bacterial meningitis is one of the most severe infectious diseases, affecting mainly infants and, secondarily, older children and adolescents. Diagnosis in the early stages is often difficult and despite treatment with appropriate antibiotic therapy, the case fatality rate remains high. In the present study, the incidence of bacterial meningitis was registered in a general pediatric hospital in Athens, Greece, during a 9-year period (2000–2008), and the use of molecular methods in the diagnosis of bacterial meningitis versus the conventional cultural methods was evaluated. The impact of vaccination against meningitis-causing bacteria on the incidence of bacterial meningitis was also assessed.
Methods: From a total of 1833 children hospitalized with suspected clinical symptoms and signs of meningitis, all cerebrospinal fluid (CSF) and blood samples were analyzed by white blood cell (WBC) count, measurement of glucose, protein, and C-reactive protein (CRP) levels, as well as by conventional bacteriologic culture methods. If samples showed altered CSF markers that were consistent with meningitis in general, they were further investigated by PCR for bacterial pathogens.
Results: Of the 1833 patients, 289 (15.76%) were found to be positive for meningitis after CSF examination, based on white blood cell count and differentiation, glucose, protein, and CRP. Fifty-six of the 289 (19.37%) had confirmed bacterial meningitis, as diagnosed by either culture and/or PCR. Of these 56 cases, 44 (78.6%) were detected only by PCR, and 12 cases (21.4%) were confirmed by PCR and culture. The predominant microorganism was Neisseria meningitidis serogroup B (n = 40; 71.4%), followed by Streptococcus pneumoniae not typed [NT] (n = 7; 12.5%), Streptococcus spp. (n = 4; 7.1%), Haemophilus influenzae NT (n = 2; 3.6%), and S. pneumoniae serotype 3, Streptococcus group B, and S. pneumoniae serotype 18C (each n=1; 1.8%).
Conclusion: In Greece, according to data from the National Meningitis Reference Laboratory, vaccination against N. meningitidis serogroup C since 2001 led to a 10-fold decrease in the incidence of meningitis cases, vaccination against S. pneumoniae serotypes included in the heptavalent conjugate vaccine since 2005 led to a 3.4-fold incidence decrease, and vaccination against H. influenzae type b since 1992 led almost to an absence of cases. In the population of the present study, none of the cases were caused by the above-mentioned vaccine pathogens, except for one S. pneumoniae serotype 18C case with no history of past vaccination.
The introduction of vaccination against meningitis-causing bacteria has drastically decreased the emergence of the infection. The improved molecular amplification assays proved to be superior to conventional bacteriologic methods and should be introduced into routine diagnosis, as well as the epidemiologic surveillance of bacterial meningitis.
This is a preview of subscription content, log in via an institution to check access.
References
World Health Organization. The world health report 2000 — health systems: improving performance [online]. Available from URL: http://www.who.int/whr/2000/en/index.html [Accessed 2011 Mar 8]
Jódar L, Feavers IM, Salisbury D, et al. Development of vaccines against meningococcal disease. Lancet 2002; 359(9316): 1499–508
Finn A. Bacterial polysaccharide-protein conjugate vaccines. Br Med Bull 2004; 70: 1–14
Harrison LH. Vaccine prevention of meningococcal disease: making slow progress. Clin Infect Dis 2006; 43(11): 1395–7
Feigin RD, Pearlman E. Bacterial meningitis beyond the neonatal period. In: Feigin RD, Demler GJ, Cherry JD, et al., editors. Textbook of pediatric infectious diseases. 5th ed. Philadelphia (PA): Saunders, 2004: 443–74
Sáez-Llorens X, McCracken Jr GH. Bacterial meningitis in children. Lancet 2003; 361(9375): 2139–48
Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000: 302-17
Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenza type b invasive disease among infants and children: United States, 1998–2000. Morb Mortal Wkly Rep 2002; 51: 234–9
Clinical and Laboratory Standards Institute [CLSI]. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard — eighth edition [CLSI document M07-A8]. Wayne (PA): CLSI, 2009 Jan
Tzanakaki G, Tsopanomichalou M, Kesanopoulos K, et al. Simultaneous single-tube PCR assay for the detection of N. meningitidis, H. influenzae type b and streptococcus pneumoniae. Clin Microb Infect 2005; 11: 386–90
Drakopoulou Z, Kesanopoulos K, Sioumala M, et al. Simultaneous single-tube PCR-based assay for the direct identification of the five most common meningococcal serogroups from clinical samples. FEMS Immunol Med Microbiol 2008; 53(2): 178–82
Sioumala M, Tzanakaki G, Levidiotou S, et al. Development of two stepdown multiplex PCR for the simultaneous detection on nine main serotypes of Streptococcus pneumoniae directly in clinical samples. Acta Microbiol Hellenica 2007; 52(3): 173–9
National Meningitis Reference Laboratory, Greek National School of Public Health. National Meningitis Reference Laboratory annual report for the year 2009 [in Greek; online]. Available from URL: http://www.nsph.gr/files/Apologismos%20EKAM%202009.pdf [Accessed 2010 Oct]
Schuurman T, de Boer RF, Kooistra-Smid AM, et al. Prospective study of use of PCR amplification and sequencing of 16S ribosomal DNA from cerebrospinal fluid for diagnosis of bacterial meningitis in a clinical setting. J Clin Microbiol 2004; 42(2): 734–40
Matos Jde A, Madureira DJ, Rebelo MC, et al. Diagnosis of Streptococcus pneumoniae meningitis by polymerase chain reaction amplification of the gene for pneumolysin. Mem Inst Oswaldo Cruz 2006; 101(5): 559–63
Rebelo MC, Boente RF, Matos Jde A, et al. Assessment of a two-step nucleic acid amplification assay for detection of Neisseria meningitides followed by capsular genogrou**. Mem Inst Oswaldo Cruz 2006; 101(7): 809–13
Acknowledgments
No sources of funding were used to conduct this study or prepare this manuscript. The authors have no conflicts of interest directly related to the content of this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Papavasileiou, K., Papavasileiou, E., Tzanakaki, G. et al. Acute Bacterial Meningitis Cases Diagnosed by Culture and PCR in a Children’s Hospital Throughout a 9-Year Period (2000–2008) in Athens, Greece. Mol Diag Ther 15, 109–113 (2011). https://doi.org/10.1007/BF03256400
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03256400